Bailong Chuangyuan: Steadily Advancing, Pioneering a Sweet New Frontier

In the booming wave of the global health industry, Bailong is writing a wonderful chapter of continuous growth in the field of functional sugar and health food ingredients with technological innovation as its pen and globalisation as its ink. Since its establishment in 2005, through years of hard work, Bailong has gradually grown from a latecomer to a leading enterprise in the industry, especially after its successful listing in 2021, it has entered the fast lane of development. Behind this achievement is the company's years of accumulation in technology research and development, capacity building and global market layout.

I. Bright half-yearly results, highlighting the strong development momentum

The release of the half-yearly report of 2025 once again let the market witness the strong development momentum of Bailongchuangyuan. During the reporting period, the company achieved a total operating income of 649 million yuan, an increase of 22.18% year-on-year, and a net profit attributable to shareholders of listed companies of 170 million yuan, an increase of 42.00% year-on-year. Behind this excellent performance is the result of the company's synergistic efforts in product structure optimisation, capacity expansion and market expansion.

In terms of product structure, the Company has continued to increase investment in research and development and launched new high value-added products, resulting in an increasingly rich and optimised product matrix. Probiotics series products, dietary fibre series products, healthy sweetener series products and other starch sugar (alcohol) products have all been well received in the market. In particular, the star product, Alozone Sugar, continues to expand its market share as the global demand for healthy low-sugar food continues to rise. As a rare sugar with a sweetness of 70% of sucrose and a taste similar to that of sucrose but with almost 0 calories, Alozone Sugar perfectly fits the current consumer's pursuit of both health and taste. As the first enterprise in China to realise the industrialised production of Alozone Sugar, Bailongchuangyuan has overcome a series of technical problems through cooperation with renowned universities at home and abroad, raising the conversion rate of the production line to 95%, and the purity of the product has reached the leading level in the industry.

In terms of production capacity, the successful commissioning of the "30,000 tonnes per annum soluble dietary fibre project" and "15,000 tonnes per annum crystalline sugar project" in May 2024 has provided strong support for the company's performance growth. The release of new production capacity not only met the growing market demand, but also further reduced production costs and enhanced the market competitiveness of the products, leading to a significant increase in product sales and sales revenue.

 II. Reviewing the achievements of previous years, a steady growth trend is evident

Looking back at the full year figures for 2021 - 2024, Bailong Chuangyuan has consistently maintained a solid growth trend. This is attributable to the company's continuous optimisation of its product mix, continuous improvement of production efficiency and reduction of production costs, as well as enhanced pricing power of its products by virtue of its brand influence and product quality advantages.

III. Driven by technological innovation to build core competitiveness

Bailongchuangyuan understands that technological innovation is the core driving force of enterprise development. Over the years, the company attaches great importance to R&D investment, has set up a high-quality R&D team, and has established long-term and stable cooperative relationships with many famous universities and research institutions at home and abroad. Up to now, the company has owned 89 domestic and foreign invention patents, covering many core aspects such as strain cultivation, production process, application scenarios, etc., and has constructed a solid technical barrier. The technological innovation of Balongchuangyuan is not only reflected in the production process, but also extended to the formulation of industry standards. By participating in the formulation of a number of national, industry and group standards, such as resistant dextrin, alloxan, oligofructose, etc., Bailong has constructed solid technical barriers while leading the direction of industry technology development.

Taking the research and development of Alozone Sugar as an example, the company has focused on research and development of new-generation products such as crystalline Alozone Sugar since 2014, and achieved industrial mass production of Liquid Alozone Sugar in 2016, and overcame the technical difficulties of crystallisation to achieve mass production in 2019, and it is a participating unit in the pre-categorisation of commodity code of Customs Import and Export Tariff Code for Alozone Sugar. At present, Bailongchuangyuan has obtained 14 patents related to Alozone Sugar, including 8 domestic patents and 6 international PCT patents, which cover various aspects such as strains, production processes and product characteristics.

In addition, the company also actively carries out application research and continuously explores new application scenarios of its products in the fields of food, beverages and healthcare products. By working closely with downstream customers and providing customised solutions, we have further enhanced the added value and market competitiveness of our products.

While consolidating the domestic market, Bailongchuangyuan actively implements the internationalisation strategy and continuously expands the global market territory. At present, the company's business has spread to more than sixty countries and regions, and its products are well recognised and praised by international customers. The company's success in the overseas market is attributed to its high quality products, strong technical research and development capabilities and perfect customer service system.

In order to be closer to the international market and meet customers' needs, the company also actively lay out production bases and R&D centres overseas. 2025 July Thailand production base officially started construction. As an important agricultural country in Southeast Asia, Thailand has abundant cassava raw material resources, and its raw material cost is lower than that in China, which provides a strong guarantee for the company to reduce production cost and improve product competitiveness. In addition, the company's R&D centre in North America is also progressing steadily. By building a global layout of "raw material base in Southeast Asia + R&D centre in North America" and "R&D close to the market and production close to the raw material", Blumtronic will further enhance its resource allocation capability and innovation capacity in the global market. By building the global layout of "Southeast Asia Raw Material Base + North America R&D Centre" and "R&D close to market and production close to raw material", Bailong Chuangyuan will further enhance its resource allocation ability and innovation ability in the global market, providing strong support for the company's future growth in international business, and weaving a sweet network of Oriental Intelligence without borders.

V. Looking to the future with a broad perspective

Looking ahead, the demand for healthy food ingredients will continue to grow as consumers around the world become more health-conscious. As a leading enterprise in the industry, Blumtronic will continue to uphold the innovation-driven development strategy, continuously optimise product structure, improve product quality and expand market share. On the basis of consolidating the advantages of existing products, the company will also continue to lay out in the fields of functional fibre and functional oligosaccharides to further improve the functional sugar industry chain.

At the same time, the company will accelerate the internationalisation process, give full play to the synergistic effect of its production base in Thailand and its R&D centre in North America, strengthen cooperation with international customers and enhance the brand's international influence. With its strong technical strength, prudent business strategy and broad market prospect, Blumtronic will be able to continue its rapid growth in the future, create greater value for shareholders and contribute more to the development of the global health industry.